B7-H4 not only promotes immunosuppressive cells in TME, such as Treg, myeloid-derived suppressor cells, and macrophages, which regulate tumor-infiltrating neutrophils, but it also inhibits the activation and subsequent effector functions of CD4 and CD8 T cells in TME [101,115]. The gene discussed is VTCN1; the disease is neoplasm.